In this motley fool article it says--and remember biogen has to disclose to the stock market---
that biogen believes the presence of the JCV is a risk factor for developing PML and is trying to get this on the label & the JCV test commercially available.
Sounds like that's their plan, so those like me who haven't had the JCV test will get it because it is on the label.
article is called Biogen Fight Back Plan---its getting the JCV test on the label.
http://www.fool.com/investing/genera...back-plan.aspx
that biogen believes the presence of the JCV is a risk factor for developing PML and is trying to get this on the label & the JCV test commercially available.
Sounds like that's their plan, so those like me who haven't had the JCV test will get it because it is on the label.
article is called Biogen Fight Back Plan---its getting the JCV test on the label.
http://www.fool.com/investing/genera...back-plan.aspx
Comment